Chemotherapy Induced Nausea and Vomiting - Market Insights, Epidemiology and Market Forecast-2023

Publisher Name :
Date: 01-Jan-2017
No. of pages: 100
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's Chemotherapy Induced Nausea and Vomiting - Market Insights, Epidemiology and Market Forecast-2023" Reports provides an overview of the disease and global market trends of the Crohn's disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Chemotherapy Induced Nausea and Vomiting forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Chemotherapy Induced Nausea and Vomiting till 2023.

Key Coverage and Benefits

  • The report will help in developing business strategies by understanding the trends shaping and driving the global Chemotherapy Induced Nausea and Vomiting market.

  • Identifying patient populations in the global "Chemotherapy Induced Nausea and Vomitingmarket to improve product design, pricing, and launch plans.

  • Organize sales and marketing efforts by identifying the best opportunities for Chemotherapy Induced Nausea and Vomiting therapeutics in each of the markets covered.

  • To understand the future market competition in the global Chemotherapy Induced Nausea and Vomiting therapeutics market and Insightful review of the key market drivers and barriers.

Scope

  • Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.

  • Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.

  • The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.

  • It also provides Chemotherapy Induced Nausea and Vomiting for United States, EU5 and Japan from 2013 and forecasted Market to 2023.

Chemotherapy Induced Nausea and Vomiting - Market Insights, Epidemiology and Market Forecast-2023

Table of Contents

Chemotherapy Induced Nausea and Vomiting overview
Pathophysiology
Symptoms of disease
Etiology of disease
Diagnosis of disease
Treatment of disease
Overview of Marketed drugs
Drug Description
Mechanism of Action
Pharmacokinetics Properties
Marketed Details
Patent Information
Patent Exclusivity Expiry Assessment United States (US)
Patents Details
Historical and Forecasted sales of marketed molecules in the Global Chemotherapy Induced Nausea and Vomiting Market
Global Epidemiology of Chemotherapy Induced Nausea and Vomiting Forecasted to 2023
Global Market (2013-2015)
Global Forecasted Market (2016-2023)
Global Market by Geography
Market of US (2013-2015)
Forecasted Market of US (2016-2023)
Market of Europe
Market of Germany (2013-2015)
Forecasted Market of Germany (2016-2023)
Market of United Kingdom (2013-2015)
Forecasted Market of United Kingdom (2016-2023)
Market of France (2013-2015)
Forecasted Market of France (2016-2023)
Market of Italy (2013-2015)
Forecasted Market of Italy (2016-2023)
Market of Spain (2013-2015)
Forecasted Market of Spain (2016-2023)
Market of Japan (2013-2015)
Forecasted Market of Japan (2016-2023)
Market of ROW (2013-2015)
Forecasted Market of ROW (2016-2023)
Appendix
Report Methodology
Consulting Services
Disclaimer
Report Purchase Options
About DelveInsight

List of Tables

Table 1: Drug Description
Table 2: Drug, Marketed Details United States (US)
Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
Table 4: Drug, Patent Details for US
Table 5: Chemotherapy Induced Nausea and Vomiting Drug Sales (USD Millions)-2023
Table 6: Global Epidemiology of Chemotherapy Induced Nausea and Vomiting (2013-2023)
Table 7: Chemotherapy Induced Nausea and Vomiting Global Market (USD Millions), (2013-2015)
Table 8: Chemotherapy Induced Nausea and Vomiting Global Market (USD Millions), (2016-2023)
Table 9: Chemotherapy Induced Nausea and Vomiting US Market (USD Millions), (2013-2015)
Table 10: Chemotherapy Induced Nausea and Vomiting US Market (USD Millions), (2016-2023)
Table 11: Chemotherapy Induced Nausea and Vomiting Germany Market (USD Millions), (2013-2015)
Table 12: Chemotherapy Induced Nausea and Vomiting Germany Market (USD Millions), (2016-2023)
Table 13: Chemotherapy Induced Nausea and Vomiting United Kingdom Market (USD Millions), (2013-2015)
Table 14: Chemotherapy Induced Nausea and Vomiting United Kingdom Market (USD Millions), (2016-2023)
Table 15: Chemotherapy Induced Nausea and Vomiting France Market (USD Millions), (2013-2015)
Table 16: Chemotherapy Induced Nausea and Vomiting France Market (USD Millions), (2016-2023)
Table 17: Chemotherapy Induced Nausea and Vomiting Italy Market (USD Millions), (2013-2015)
Table 18: Chemotherapy Induced Nausea and Vomiting Italy Market (USD Millions), (2016-2023)
Table 19: Chemotherapy Induced Nausea and Vomiting Spain Market (USD Millions), (2013-2015)
Table 20: Chemotherapy Induced Nausea and Vomiting Spain Market (USD Millions), (2016-2023)
Table 21: Chemotherapy Induced Nausea and Vomiting Japan Market (USD Millions), (2013-2015)
Table 22: Chemotherapy Induced Nausea and Vomiting Japan Market (USD Millions), (2016-2023)
Table 23: Chemotherapy Induced Nausea and Vomiting ROW Market (USD Millions), (2013-2015)
Table 24: Chemotherapy Induced Nausea and Vomiting ROW Market (USD Millions), (2016-2023)

List of Figures

Figure 1: Chemotherapy Induced Nausea and Vomiting Drug Sales (USD Millions)-2023
Figure 2: Global Epidemiology of Chemotherapy Induced Nausea and Vomiting (2013-2023)
Figure 3: Chemotherapy Induced Nausea and Vomiting Global Market (USD Millions), (2013-2015)
Figure 4: Chemotherapy Induced Nausea and Vomiting Global Market (USD Millions), (2016-2023)
Figure 5: Chemotherapy Induced Nausea and Vomiting US Market (USD Millions), (2013-2015)
Figure 6: Chemotherapy Induced Nausea and Vomiting US Market (USD Millions), (2016-2023)
Figure 7: Chemotherapy Induced Nausea and Vomiting Germany Market (USD Millions), (2013-2015)
Figure 8: Chemotherapy Induced Nausea and Vomiting Germany Market (USD Millions), (2016-2023)
Figure 9: Chemotherapy Induced Nausea and Vomiting United Kingdom Market (USD Millions), (2013-2015)
Figure 10: Chemotherapy Induced Nausea and Vomiting United Kingdom Market (USD Millions), (2016-2023)
Figure 11: Chemotherapy Induced Nausea and Vomiting France Market (USD Millions), (2013-2015)
Figure 12: Chemotherapy Induced Nausea and Vomiting France Market (USD Millions), (2016-2023)
Figure 13: Chemotherapy Induced Nausea and Vomiting Italy Market (USD Millions), (2013-2015)
Figure 14: Chemotherapy Induced Nausea and Vomiting Italy Market (USD Millions), (2016-2023)
Figure 15: Chemotherapy Induced Nausea and Vomiting Spain Market (USD Millions), (2013-2015)
Figure 16: Chemotherapy Induced Nausea and Vomiting Spain Market (USD Millions), (2016-2023)
Figure 17: Chemotherapy Induced Nausea and Vomiting Japan Market (USD Millions), (2013-2015)
Figure 18: Chemotherapy Induced Nausea and Vomiting Japan Market (USD Millions), (2015-2023)
Figure 19: Chemotherapy Induced Nausea and Vomiting ROW Market (USD Millions), (2013-2015)
Figure 20: Chemotherapy Induced Nausea and Vomiting ROW Market (USD Millions), (2016-2023)

  • Chemotherapy Induced Neutropenia (CIN) -Market Insights, Epidemiology and Market Forecast-2023
    Published: 24-Mar-2017        Price: US 4950 Onwards        Pages: 132
    Summary DelveInsight’s “Chemotherapy Induced Neutropenia (CIN) – Market Insights, Epidemiology and Market Forecast-2023” Report provides an overview of the disease and global market trends of the Chemotherapy Induced Neutropenia for the seven major markets i.e., United States, Europe (France, Germany, Italy, Spain, UK) and Japan, as well as rest of Europe (RoE) and rest of the world (RoW). The Report covers the therapeutics mar......
  • Oral Mucositis - Pipeline Review, H1 2017
    Published: 22-Mar-2017        Price: US 2000 Onwards        Pages: 91
    Oral Mucositis - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Oral Mucositis - Pipeline Review, H1 2017, provides an overview of the Oral Mucositis (Oncology) pipeline landscape. Oral mucositis is the most common type of mucositis. It is a debilitating complication of cancer surgery, chemotherapy and radiation. Symptoms include change in color, hyposalivation, a change in the inte......
  • Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2017
    Published: 08-Mar-2017        Price: US 2000 Onwards        Pages: 88
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2017, provides an overview of the Chemotherapy Induced Nausea and Vomiting (Oncology) pipeline landscape.Chemotherapy induced nausea and vomiting or CINV is nausea and vomiting that results specifically from treatment with chemotherapy drugs. Symptoms include a rapid heart rate, sweating, dizziness and increased saliva. Risk factors include age, dr......
  • Chemotherapy Induced Neutropenia - Pipeline Review, H1 2017
    Published: 08-Mar-2017        Price: US 2000 Onwards        Pages: 107
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chemotherapy Induced Neutropenia - Pipeline Review, H1 2017, provides an overview of the Chemotherapy Induced Neutropenia (Oncology) pipeline landscape.Chemotherapy-induced neutropenia is a very common side effect of cancer treatment. Symptoms include severe fatigue, weakness, anxiety, lack of energy, shortness of breath, headaches, pale appearance, rapid heart rate or palpitations, chest pain dizziness and ab......
  • Estrogen Receptor Positive (ER+) Breast Cancer - Treatment Landscape & Competitive Analysis, 2017
    Published: 01-Mar-2017        Price: US 2450 Onwards        Pages: 90
    DelveInsight's, "Estrogen Receptor Positive (ER+) Breast Cancer - Treatment Landscape & Competitive Analysis, 2017", report provides comprehensive insights about the treatment landscape across this indication. This report also provides the deep understanding of the stages of the Estrogen Receptor Positive (ER+) Breast Cancer, epidemiology, risk factors, diagnosis etc. A key objective of the report is to establish the understanding of the treatment landscape and competitive analysis of the Estrog......
  • Ovarian Cancer - Treatment Landscape & Competitive Analysis, 2017
    Published: 01-Mar-2017        Price: US 2450 Onwards        Pages: 90
    DelveInsight's, "Ovarian Cancer - Treatment Landscape & Competitive Analysis, 2017", report provides comprehensive insights about the treatment landscape across this indication. This report also provides the deep understanding of the stages of the ovarian cancer, epidemiology, risk factors, diagnosis etc. A key objective of the report is to establish the understanding of the treatment landscape and competitive analysis of the Ovarian Cancer which mainly describes the treatment of ovarian cancer ......
  • Chimeric Antigen Receptor (CAR) T cell Immunotherapy - Competitive Landscape, Pipeline and Market Analysis, 2017
    Published: 01-Mar-2017        Price: US 2750 Onwards        Pages: 365
    DelveInsight's, "Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Pipeline and Market Analysis, 2017", report provides comprehensive insights about marketed and pipeline drugs across this Mechanism of action. Key objective of the report is to establish the understanding for all the marketed and pipeline drugs that fall under Chimeric Antigen Receptor (CAR) T cell Immunotherapy. This report provides information on the therapeutic development based on Chimeric Antigen ......
  • Global Personalized Medicine in Oncology Partnering Terms and Agreements 2010 to 2017
    Published: 01-Feb-2017        Price: US 2995 Onwards        Pages: 470
    "Delivery of this report will take 1-3 days after purchase." Summary The Global Personalized Medicine in Oncology Partnering Terms and Agreements 2010 to 2017 report provides comprehensive understanding and unprecedented access to the personalized medicine in oncology partnering deals and agreements entered into by the worlds leading healthcare companies. Description The Global Personalized Medicine in Oncology Partneri......
  • Global Mucositis Partnering 2010-2017
    Published: 01-Feb-2017        Price: US 1495 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." Summary Provides understanding and access to the mucositis partnering deals and agreements entered into by the worlds leading healthcare companies Description The Global Mucositis Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies.......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs